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E-mail address: nadano@agr.nagoya-u.ac.jp (D. NaMicrotubules form ﬂexible ﬁbers, which are utilized in cell proliferation and differentiation.
Although the ﬂexibility of microtubules was shown to be regulated by various microtubule-associ-
ated proteins, this regulation is still far from complete understanding. Here, we report a new poten-
tial regulator of microtubules in mammals. Gcap14 colocalizes with microtubules in mammalian
cells transfected with Gcap14 expression vector. Association of Gcap14 with microtubules was con-
ﬁrmed by biochemical subcellular fractionation. Recombinant Gcap14 protein cosedimented with
pure microtubules, indicating a direct binding between the two. Furthermore, recombinant Gcap14
was shown to have the ability of inducing microtubule bundling in vitro.
Structured summary of protein interactions:
Gcap14 physically interacts with Gcap14 by anti tag coimmunoprecipitation (View Interaction: 1, 2)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cytoskeletons, like bones in the human body, physically support
lipid membrane-enclosed fragile cells in animals and determine
cell morphology. In addition, cytoskeletons play roles in various
processes in the cell, including cell movement and intracellular
transport. To adapt to these roles promptly, cytoskeletons change
their shape dynamically. For example, polymerization and depoly-
merization of microtubules (MTs) are intrinsically stochastic,
which has been called the dynamic instability [1]. This ﬂexibility
is, however, necessary to be regulated to play the roles in the cell;
dysregulation of intracellular MTs often leads to diseases including
neurodegenerative diseases [2,3]. Many cytoplasmic proteins have
been reported to be associated with MTs and to be essential for MT
regulation [4,5]. However, the detailed mechanisms of the regula-
tion largely remain to be clariﬁed.
The mammary gland has a unique developmental cycle: cell
proliferation in response to pregnancy, differentiation of the epi-
thelial cells for milk secretion, and a regressive phase after wean-
ing (involution), including extensive death of the secretory
epithelial cells and tissue remodeling, for returning to a pre-preg-
nant state [6–8]. To know the mechanisms underlying this mam-
mary cycle, we have screened murine genes potentially included
in these events in the cycle [9–12]. During the course of thischemical Societies. Published by E
pplied Molecular Biosciences,
niversity, Furo-cho, Chikusa,
dano).screening, we have identiﬁed a previously uncharacterized gene,
Gcap14. A translated product of this gene has been found to bind
speciﬁcally to MTs and bundle them in vitro.
2. Materials and methods
2.1. Cloning and expression of mouse Gcap14 cDNA
Mouse cDNA including the full-length coding region of Gcap14
(encoding a 485-aa polypeptide, GenBank ID: NM_028407) was
obtained from the mouse mammary gland, according to our
previous work including total RNA extraction and reverse tran-
scription-PCR [9]. The cDNA fragment was subcloned in pCMV-
Tag2B (Agilent Technologies), pcDNA3.1/Myc-His (Invitrogen),
and pEGFP-c1 (BD Biosciences Clontech) to express Gcap14 protein
with the N-terminal FLAG, C-terminal Myc-His, and N-terminal
green ﬂuorescent protein (GFP) tags in mammalian cells, respec-
tively. The same cDNA was also subcloned into a pMAL-c2 vector
(New England BioLabs) to express recombinant Gcap14 protein
fused with maltose binding protein (MBP) in bacteria.
Culture of mammalian cell lines and vector transfection by lip-
ofection were described previously [10,13]. For complete depoly-
merization of intracellular MT ﬁbers, cells were treated with the
combination of nocodazole and cold temperature [14].
2.2. Biochemical and immunochemical methods
Proteins were determined by the BCA assay (Piece). SDS-poly-
acrylamide gel electrophoresis (PAGE), Coomassie R-250 staining,lsevier B.V. All rights reserved.
H. Hosono et al. / FEBS Letters 586 (2012) 1426–1430 1427electroblotting, and immunodetection with primary and peroxi-
dase-labeled secondary antibodies were performed as described
previously [11,13]. The following antibodies were used as the pri-
mary antibody: rabbit antibodies against GFP and the His tag from
MBL (Nagoya, Japan), mouse monoclonal antibodies against the
FLAG tag (M2) and a-tubulin from Sigma, mouse monoclonal
anti-glyderaldehyde-3-phosphate dehydrogenase (GAPDH) anti-
body from HyTest, and guinea pig anti-cytokeratins 8/18 antibody
from Progen.
Cells on coverslips were ﬁxed with glutaraldehyde, methanol, or
the Cytoskelﬁx reagent (Cytoskeleton, Denver, CO, USA), stained
with primary and ﬂuorophore-labeled secondary antibodies, and
observed under ﬂuorescence and confocal microscopes [15,16].
After transfection of MCF-7 cells with the FLAG–Gcap14 expres-
sion vector, subcellular fractionation under MT-stabilized and MT-
depolymerized conditions was performed as described previously
[16,17]. Brieﬂy, under MT-stabilized conditions, cells were pre-
treated with paclitaxel (taxol) and lysed with MT-stabilizing buffer
plus NP-40. Under MT-depolymerized conditions, intracellular MTs
were completely depolymerized as described above, and cells were
then lysed with Tris buffer including NP-40 and EDTA. These cell
lysates were centrifuged to obtain the supernatant and precipitate
fractions. An equivalent amount of each fraction was subjected to
immunoblotting with antibodies against the FLAG tag, a-tubulin,
GAPDH, and cytokeratins 8/18. GAPDH and cytokeratins 8/18 were
used as the markers for free cytosolic proteins and cytoskeletal ﬁ-
bers, respectively.
2.3. Recombinant Gcap14 protein and in vitro MT-cosedimentation
assay
Recombinant Gcap14 fused with MBP was expressed in Esche-
richia coli BL21 by transformation with its expression vector de-
scribed above and puriﬁed with maltose-conjugated beads (New
England BioLabs). These procedures were basically according to
manufacturer’s instructions except for the following two points.
(1) Bacteria were cultured at 20 C in protein induction. (2) After
trapping of recombinant MBP–Gcap14 on the maltose resin, two-
step elution was performed with 0.1 and 3.0 mM maltose. Under
these ﬁnal elution conditions, the majority of the putative full-
length product (calculated molecular mass, 97 kDa) was eluted
with 3.0 mM maltose, as judged by SDS-PAGE. MBP was also ex-
pressed by using pMAL-c2 (no insert) and puriﬁed by the same
procedure. Puriﬁed proteins were dialyzed at 4 C against 80PEM
buffer (80 mM Pipes, pH 6.9, including 2 mM MgCl2 and 0.5 mM
EGTA), centrifuged brieﬂy, and stored at 4 C until use.
For in vitro MT-cosedimentation assay, each puriﬁed recombi-
nant protein in 80PEM buffer was mixed with Triton X-100, GTP,
and paclitaxel, whose ﬁnal concentrations were 0.5%, 1 mM, and
20 lM, respectively, and ultracentrifuged at 100000g for 60 min
at 30 C to remove a trace of insoluble material. Pure porcine brain
tubulin dimer (>99% purity, Cytoskeleton) was polymerized in the
presence of paclitaxel [16]. Each recombinant protein (0.2 nmol)
was then mixed with porcine brain MTs (corresponding to
0.5 nmol of tubulin dimer) in 80PEM buffer, including 0.5% Triton
X-100, and subjected to ultracentrifugation at 100000g for
15 min at 30 C to separate the supernatant (S100) and precipitate
(P100). After a brief wash of P100 with 80PEM buffer, the S100 and
P100 fractions were subjected to SDS-PAGE (7.5% gel) followed by
Coomassie staining.
2.4. In vitro MT-bundling assay
This assay was performed in accordance with the previous
reports [18,19] with a slight modiﬁcation. Each puriﬁed recombi-
nant protein was mixed with Triton X-100 and GTP, whose ﬁnalconcentrations were 0.5% and 1 mM, respectively, and centrifuged
at 20000g for 15 min at room temperature. Pure porcine brain
tubulin dimer (0.1 nmol) and 0.01 nmol of HiLyte 488 dye-conju-
gated porcine brain tubulin dimer (Cytoskeleton) were mixed in
80PEM, including 1 mM GTP buffer and 20 lM paclitaxel, and kept
for 15 min at room temperature to form ﬂuorescent MT ﬁbers. The
puriﬁed MBP–Gcap14 or MBP (0.01 nmol) was added to the ﬂuo-
rescent MT ﬁbers and incubated for 10 min at room temperature.
The mixture was then diluted ten times with 1% glutaraldehyde
in 80PEM (including 1 mM GTP)/100% glycerol (1:1), spotted onto
a slide glass, and covered with a coverslip for observation under a
ﬂuorescence microscope (IX71, Olympus) equipped with a 40
objective. To examine the structure of thick, bundled MTs, the ﬁxed
samples were further diluted ﬁve times with the same ﬁxation buf-
fer to minimize accidental overlap of MT ﬁlaments. Individual MT
bundles were then observed under a confocal laser microscope
(FV1000-D, Olympus) with a 100 objective.
2.5. Immunoprecipitation
Cells were subjected to the complete MT depolymerization de-
scribed above, lysed with 50 mM Tris–HCl, pH 7.5, containing
0.15 M NaCl, 1% NP-40, 1 mM EDTA, 1 mM phenylmethylsulfonyl
ﬂuoride, 50 lM proteasome inhibitor I (PSI), 10 lg/ml aprotinin,
5 lg/ml leupeptin, and 5 lg/ml pepstatin A, and centrifuged twice
at 20000g for 15 min at 4 C. The subsequent procedures were per-
formed using the supernatants, appropriate antibodies, and protein
G-conjugated beads, essentially according to our previous report
[12].
2.6. Preparation of antibodies against mouse Gcap14
cDNA encoding the C-terminal half of mouse Gcap14 protein
(residues 222–485) was ampliﬁed by PCR and subcloned into the
pET-32a (+) vector (Novagen) to express the Gcap14 fragment
fused with thioredoxin in bacteria. The thioredoxin-fused protein
was expressed in E. coli BL21 and puriﬁed by using the His-bind re-
sin (Novagen) according to manufacturer’s instructions. Antisera
were raised in two rabbits using the puriﬁed thioredoxin-fused
protein as the immunogen.
For the preparation of mouse antisera against Gcap14, the thio-
redoxin tag was removed from the C-terminal Gcap14 fragment by
using a His-bind resin column after cleavage with enterokinase
(Novagen). Four male ddY mice were immunized by injection of
the Gcap14 fragment separated from the thioredoxin tag. The
immunization procedures were based on our previous report
[10]. Blood was collected from individual mice, and collected sera
were used.
2.7. Preparation of MT-rich fraction from the mouse brain
The MT-rich fraction was prepared from the brain by MT disas-
sembly/assembly in buffer containing glycerol, essentially accord-
ing to the literature [20]. Brieﬂy, the fresh mouse brain (about
0.4 g) was homogenized on ice in 0.2 ml 80PEM buffer and centri-
fuged at 22300g for 60 min at 4 C. The supernatant was mixed
with an equal volume of 80PEM buffer, including 8 M glycerol
and 1 mM GTP, kept at 37 C for 60 min, and ultracentrifuged at
100000g for 60 min at 37 C. The clear pellet, including MTs and
their associated proteins, was dissolved in the SDS-PAGE sample
buffer, boiled, and subjected to SDS-PAGE.
2.8. MT stability assay
COS-1 cells plated on coverslips were transfected with the GFP–
Gcap14 expression vector as described above. After 24 h of trans-
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37 C, ﬁxed with cold methanol, and subjected to immunoﬂuores-
cence with anti-a-tubulin antibody.
3. Results
3.1. Overexpressed Gcap14 colocalized with MTs
After isolation of Gcap14 cDNA from mouse cerebellar granule
cells [21], no functional data on the translated product have been
published. Hence, Gcap14 with the three different tags (FLAG,
GFP, and Myc-His) was expressed in mammalian culture cells,
including COS-1, HEK293T, HeLa, and MCF-7 cells (Fig. 1 and data
not shown). In Fig. 1A, the mobility of FLAG-tagged Gcap14 was
smaller than that of its calculated molecular mass (54 kDa). This
low mobility might be explained by a high content of proline res-
idues (10%) of this protein.
In the interphase of the transfected cell, FLAG-tagged Gcap14
showed ﬁlamentous structures, which colocalized with MTs
(Fig. 1B). Similar colocalization was observed when Gcap14 with
the other tags was expressed in culture cells (the upper panels of
Fig. 1C and data not shown). To test this colocalization further,
MTs were depolymerized with nocodazole, a reagent speciﬁcally
depolymerizing MTs, in Gcap14-overexpressing cells. FilamentousFig. 1. Colocalization of Gcap14 and MTs. (A) Immunoblotting of FLAG-tagged
Gcap14. COS-1 cells were transiently transfected with the vector for expression of
FLAG–Gcap14, lysed with the SDS-PAGE sample buffer, and subjected to SDS-PAGE
followed by immunodetection with anti-FLAG antibody. Molecular mass markers
are indicated on the left. (B) Immunocytochemistry of FLAG–Gcap14. COS-1 cells
transfected with the same expression vector were ﬁxed with the Cytoskelﬁx
reagent and subjected to double immunostaining with antibodies against a-tubulin
and the FLAG tag. The MT-organizing centers in untransfected cells are indicated by
the arrows. (C) Effect of MT depolymerization. COS-1 cells were transfected with
the Gcap14–Myc-His expression vector, subjected to treatment with nocodazole
(plus cold temperature) or no treatment, ﬁxed with glutaraldehyde, subjected to
double immunostaining with antibodies against the His tag and a-tubulin, and
observed under a ﬂuorescence microscope. (D) Gcap14 in mitosis. MCF-7 cells
transfected with the GFP–Gcap14 expression vector were subjected to immuno-
ﬂuorescence microscopy including DNA staining with TOTO-3. Bars, 10 lm.structures of MTs and Gcap14 were disrupted under these condi-
tions (the lower panels of Fig. 1C). Although it is generally possible
that the intracellular localization of an overexpressed protein in-
cludes artifacts, this observation after speciﬁc perturbation of
MTs suggested that Gcap14 could be associated with MTs in the
cell. In the mitosis of the transfected cell, colocalization of Gcap14
and MTs was not evident, and most of Gcap14 was diffused uni-
formly within the cell (Fig. 1D). Overall, these immunocytochemi-
cal data revealed an unexpected link between Gcap14 and MTs.
3.2. Subcellular fractionation supported speciﬁc association of Gcap14
with MTs
To examine the putative association of Gcap14 with MTs by a
different method, subcellular fractionation was performed using
cells overexpressing Gcap14 (Fig. 2). Under MT-stabilized condi-
tions, under which cellular MT ﬁbers were stabilized by paclitaxel,
MTs were sedimented by centrifugation after mild cell lysis.
Gcap14 was also sedimented under these conditions. In contrast,
Gcap14 and MTs were not sedimented under the conditions where
MTs were depolymerized by the pre-treatment with nocodazole
and cold temperature. Fractionation of another cytoskeleton,
cytokeratins, and a free cytosolic protein, GAPDH, was not affected
under these two conditions, as reported previously [16]. This
biochemical result supported speciﬁc association of Gcap14 with
MTs in the cell.
3.3. Recombinant Gcap14 protein was indicated to bind directly to MTs
To examine binding between Gcap14 and MTs in vitro, recom-
binant MBP-fused Gcap14 was prepared in bacteria and puriﬁed
by using immobilized maltose (Fig. 3A). The combination of
bacterial culture at low temperature and step-wise elution of
MBP–Gcap14 from the maltose-conjugated resin minimized
contamination of partially degraded products. Recombinant
MBP-fused Gcap14 was cosedimented with pure MTs by ultracen-
trifugation (Fig. 3B); in contrast, MBP itself was not (Fig. 3C). These
data indicated direct binding of Gcap14 to MTs.
3.4. Gcap14 induced MT bundling in vitro
Immunostaining of the cell expressing Gcap14 revealed thick
ﬁlaments of interphase MTs (Fig. 1B). These ﬁlaments were appar-
ently reorganized and in contrast to those of the control cell where
numerous ﬁne MT ﬁbers radiated from the MT-organizing centerFig. 2. Subcellular fractionation under MT-stabilized and MT-depolymerized con-
ditions. MCF-7 cells were transiently transfected with the FLAG–Gcap14 expression
vector and kept under the conditions where MTs were stabilized by paclitaxel.
Another cells transiently transfected with the same vector were kept under the
conditions where MTs were depolymerized by treatment with nocodazole. Cells
were then lysed with NP-40 and subjected to centrifugation. The supernatants (S)
and precipitates (P) were subjected to immunoblotting with the antibodies
indicated on the left.
Fig. 3. Direct binding of Gcap14 to MTs. (A) Recombinant Gcap14 protein. Gcap14
fused with MBP and MBP (no fusion) were expressed in bacteria, puriﬁed with
immobilized maltose, and subjected to SDS-PAGE followed by Coomassie staining.
Molecular mass markers are indicated on the left. (B and C) In vitro MT
cosedimentation assay. The puriﬁed MBP–Gcap14 (B) or MBP (C) was mixed with
MTs, which had been prepared by polymerization of pure tubulin dimers by
paclitaxel, and subjected to ultracentrifugation. The supernatants (S) and precip-
itates (P) were subjected to SDS-PAGE followed by Coomassie staining. The lanes
showing precipitated MTs are indicated by the asterisks.
Fig. 4. Promoted bundling of MTs by Gcap14. (A) In vitro MT bundling assay.
Puriﬁed MBP–Gcap14 or MBP was mixed with ﬂuorophore-labeled MTs, kept for
10 min, and subjected to ﬂuorescence microscopy. Fluorescent images at low and
high magniﬁcations are shown. Each high-magniﬁcation image is a single confocal
section of an MT bundle. Bundled thin MT ﬁlaments are indicated by the
arrowheads. Bars, 5 lm. (B) Co-immunoprecipitation of Gcap14 proteins with the
different tags. MCF-7 cells were transfected doubly with the expression vectors for
FLAG–Gcap14 and GFP–Gcap14, lysed with NP-40 after MT depolymerization, and
subjected to immunoprecipitation (IP) with antibody against the FLAG tag (left
column) or the GFP tag (right column). Normal IgG was used as a negative control.
The obtained immune complexes were subjected to immunoblotting (IB) with
antibodies against the FLAG and GFP tags. (C) No association of Gcap14 with GFP
itself. MCF-7 cells were transfected doubly with the expression vectors for FLAG–
Gcap14 and GFP (no fusion) and subjected to the same immunoprecipitation
experiments as described in (B).
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the amount of sedimented MTs was increased reproducibly in the
presence of recombinant Gcap14 (the lane indicated by the asterisk
in Fig. 3B), as compared to that of the control (the lane indicated by
the asterisk in Fig. 3C). These results stimulated us to test a possi-
bility that MTs could be bundled by Gcap14. When recombinant
MBP–Gcap14 was mixed with ﬂuorophore-labeled MTs in vitro,many thick MT ﬁlaments were observed under a ﬂuorescence
microscope (Fig. 4A). Microscopic observation at high magniﬁca-
tion suggested bundling of thin MT ﬁlaments (indicated by the
arrowheads in the lower two panels of the ﬁgure). It is very unli-
kely that this MT reorganization is achieved by aggregation of
MBP (in combination with MT-binding of Gcap14) because self-
association of MBP has not been observed by analysis including
cryoelectron microscopy [22]. The results of this assay indicated
that Gcap14 had an ability not only to bind to MTs but also to bun-
dle them.
Since Gcap14 has no obvious homology to known proteins,
including MT-associated proteins [4,5], the molecular mechanism
for bundling of MTs by Gcap14 is currently unclear. Interestingly,
when GFP–Gcap14 and FLAG–Gcap14 were co-expressed in a cell,
these tagged Gcap14 proteins were suggested be included in the
same complex by immunoprecipitation (Fig. 4B). To prevent the
indirect association of these Gcap14 proteins mediated through
MT binding, intracellular MTs were completely depolymerized be-
fore lysis of the transfected cells. Because GFP and FLAG–Gcap14
were not co-immunoprecipitated from the cells co-transfected
with the vectors for these two proteins (Fig. 4C), the above-ob-
served association was not caused by binding of Gcap14 to the
GFP tag or by non-speciﬁc aggregation of overexpressed proteins.
These data imply that association of two or more Gcap14 mole-
cules contributes to its MT-bundling activity by cross-bridging
MT ﬁlaments. However, the association of Gcap14 proteins was ob-
served under conditions of overexpression, and it is unclear
whether the association occurs by direct binding of Gcap14 pro-
teins or by help of another molecule. Further analysis is obviously
necessary to dissect the mechanism of MT bundling by Gcap14.
In summary, Gcap14 was indicated to have an ability not only to
bind to MTs but also to bundle them.
3.5. Gcap14 protein was expressed in the brain and stabilized MT ﬁbers
in COS-1 cells
In this study, expression of cloned cDNA encoding mouse
Gcap14 in culture cells indicated the relationship between Gcap14
and MTs, and the in vitro functions of Gcap14 protein (binding and
bundling of MTs) were revealed. These raised the following two
important questions: whether Gcap14 protein existed in cell lines
or animals, and whether Gcap14 affected MT properties in the cell.
To address the former question, we prepared rabbit anti-
Gcap14 antisera using the recombinant C-terminal half of mouse
Gcap14 protein, which was fused with thioredoxin. While these
antisera showed positive reactivity to overexpressed Gcap14 pro-
tein in cells, endogenous Gcap14 in the mouse tissues failed to
be detected by the antisera (data not shown), probably due to
low avidity of the antisera. Thus, the C-terminal half of Gcap14
was separated from thioredoxin and immunized in four mice.
Antiserum from one of the four immunized mice showed speciﬁc
reactivity to overexpressed Gcap14 (Fig. 5A, left lane). By immuno-
blotting with this antiserum, a putative Gcap14 band was detected
in the crude homogenate of the mouse brain (Fig. 5A, right lane),
from which cDNA of this protein was originally identiﬁed [21],
indicating the existence of Gcap14 protein in vivo. In addition,
the Gcap14 band was detected in the MT-rich fraction of the mouse
brain, which was prepared by MT disassembly/assembly (Fig. 5B),
suggesting the association of endogenous Gcap14 with MTs.
We examined the stability of MTs in cells overexpressing
Gcap14 to address the latter question. COS-1 cells were transiently
transfected with the GFP–Gcap14 expression vector and subjected
to mild nocodazole treatment. While most of MTs were depoly-
merized in untransfected cells, many MT ﬁbers were observed in
cells transfected with the vector (Fig. 5C). MT stabilization may
be one of the functions of intracellular Gcap14.
Fig. 5. Endogenous expression and putative function of Gcap14 protein. (A)
Immunoblotting with mouse antiserum against Gcap14. Left lane, whole lysate of
MCF-7 cells overexpressing FLAG–Gcap14; right lane, whole lysate of the mouse
brain (corresponding to 0.3 mg of wet weight tissue). (B) Analysis of the MT-rich
fraction of the mouse brain. The fraction, including MTs and their associated
proteins, was obtained from the mouse brain and subjected to SDS-PAGE. The gels
were then subjected to immunodetection with mouse antiserum against Gcap14
(left panel) and Coomassie (CBB) staining (right panel). The arrowheads in the right
panel indicate a- and b-tubulins as major components in this fraction. Molecular
mass markers are indicated. (C) MT stability assay. COS-1 cells were transiently
transfected with the GFP–Gcap14 expression vector, cultured for 24 h, incubated
under mild MT-depolymerizing conditions, and subjected to immunoﬂuorescence
microscopy. A cell overexpressing GFP–Gcap14 and an untransfected cell are
indicated by the arrows and the arrowhead, respectively. Bar, 10 lm.
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This study pointed out, for the ﬁrst time, the function of a trans-
lated product of the Gcap14 gene. It was indicated that Gcap14 was
associated with MTs in the cell by its direct binding to them and
promoted bundling them in vitro. The physiological importance
of these properties of this protein awaits further studies. Homologs
of Gcap14 were identiﬁed in mammals and chicken, but not in
yeast or ﬂy, according to our database search. Hence, this protein
seems to have a modulatory role in MT organization in higher ani-
mals such as mammals. The developmental cycle of the mammary
gland (see Section 1) requires timely changes in cell population of
this tissue. For this purpose, the shape, mobility, and viability of
speciﬁc groups of cells are dynamically altered in the mammary
gland [6–8], which appears to be supported by regulated cytoskel-
etons including MTs. Few MT-bundling proteins have been identi-
ﬁed to date, and their functional data are still limited, as compared
to other subgroups of MT-associated proteins, including classical
MT-stabilizing proteins [2,4,5,23]. Our ﬁndings have revealed a po-
tential regulator of MTs, whose further analysis may shed a new
light on control mechanisms for intracellular MTs.Acknowledgements
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